Join
Live feed
·
INSIDERFilingvia Quantisnow
Precision BioSciences Inc. logo

President and CEO Amoroso Michael converted options into 9,444 shares and sold $22,124 worth of shares (3,409 units at $6.49), increasing direct ownership by 6% to 115,575 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DTIL· Precision BioSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DTIL (Precision BioSciences Inc.) and more on Quantisnow.